Figure 2.
Meta-analysis for V2Vt and V2Vt subintervals. V2Vt and V2Vt subintervals for axi-cel (A), tisa-cel (B), and liso-cel (C). The median days of V2Vt and V2Vt subintervals and 95% CIs are represented by brown diamonds for all studies and by green squares with error bars for subgroups. One clinical trial in patients treated with axi-cel that reported a median of 13.0 days for leukapheresis-to-product release (eg, when the product passed quality control testing and was made available to the investigator) interval was not presented because the study did not report a 95% CI.

Meta-analysis for V2Vt and V2Vt subintervals. V2Vt and V2Vt subintervals for axi-cel (A), tisa-cel (B), and liso-cel (C). The median days of V2Vt and V2Vt subintervals and 95% CIs are represented by brown diamonds for all studies and by green squares with error bars for subgroups. One clinical trial in patients treated with axi-cel that reported a median of 13.0 days for leukapheresis-to-product release (eg, when the product passed quality control testing and was made available to the investigator) interval was not presented because the study did not report a 95% CI.

or Create an Account

Close Modal
Close Modal